![](/img/cover-not-exists.png)
Cost-effectiveness of ceftolozane/tazobactam compared with piperacillin/tazobactam as empiric therapy based on the in-vitro surveillance of bacterial isolates in the United States for the treatment of complicated urinary tract infections
Kauf, Teresa L, Prabhu, Vimalanand S., Medic, Goran, Borse, Rebekah H., Miller, Benjamin, Gaultney, Jennifer, Sen, Shuvayu S., Basu, AnirbanVolume:
17
Language:
english
Journal:
BMC Infectious Diseases
DOI:
10.1186/s12879-017-2408-7
Date:
December, 2017
File:
PDF, 781 KB
english, 2017